{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:42:29Z","timestamp":1782736949252,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"am","delay-in-days":329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001843","name":"SERB","doi-asserted-by":"publisher","award":["EMR\/2014\/001127"],"award-info":[{"award-number":["EMR\/2014\/001127"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"CSIR India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007917","name":"Department of Agriculture (USDA), United States Agricultural Research Service","doi-asserted-by":"publisher","award":["58-6408-2-0009"],"award-info":[{"award-number":["58-6408-2-0009"]}],"id":[{"id":"10.13039\/100007917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejmech.2018.11.021","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T16:54:36Z","timestamp":1541782476000},"page":"277-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["N-Substituted aminoquinoline-pyrimidine hybrids: Synthesis, in\u00a0vitro antimalarial activity evaluation and docking studies"],"prefix":"10.1016","volume":"162","author":[{"given":"Shiv S.","family":"Maurya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Bahuguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabana I.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Kholiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5473-7476","authenticated-orcid":false,"given":"Diwan S.","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.11.021_bib1","series-title":"World Malaria Report","author":"WHO","year":"2017"},{"key":"10.1016\/j.ejmech.2018.11.021_bib2","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2174\/1568026614666140808125728","article-title":"4-Aminoquinoline based molecular hybrids as antimalarials: an overview","volume":"14","author":"Manohar","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.021_bib3","unstructured":"Centers for Disease Control. The history of malaria, an ancient disease, http:\/\/www.cdc.gov\/malaria\/history\/index.htm#chloroquine."},{"key":"10.1016\/j.ejmech.2018.11.021_bib4","doi-asserted-by":"crossref","first-page":"11164","DOI":"10.1021\/cr500123g","article-title":"Recycling classical drugs for malaria","volume":"114","author":"Teixeira","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.11.021_bib5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrd4573","article-title":"Malaria medicines: a glass half full","volume":"14","author":"Wells","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.11.021_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro2331","article-title":"Artemisinin resistance: current status and scenarios for containment","volume":"8","author":"Dondorp","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2018.11.021_bib7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2018.11.021_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2018.11.021_bib9","doi-asserted-by":"crossref","first-page":"11138","DOI":"10.1021\/cr500098f","article-title":"Recent approaches to chemical discovery and development against malaria and the neglected tropical diseases human African trypanosomiasis and schistosomiasis","volume":"114","author":"Njoroge","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.11.021_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ar7000843","article-title":"Hybrid molecules with a dual mode of action: dream or reality","volume":"41","author":"Meunier","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.11.021_bib11","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2174\/1568026614666140808125728","article-title":"4-aminoquinoline based molecular hybrids as antimalarials: an overview","volume":"14","author":"Manohar","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.021_bib12","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1016\/j.bmc.2015.04.017","article-title":"From hybrid compounds to targeted drug delivery in antimalarial therapy","volume":"23","author":"Oliveira","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.021_bib13","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1351\/pac200880081693","article-title":"Multi target drugs: focus on the NO-donor hybrid drugs","volume":"80","author":"Gasco","year":"2008","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.ejmech.2018.11.021_bib14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bmcl.2009.10.106","article-title":"Synthesis, antimalarial activity and cytotoxicity of 4 aminoquinoline-triazine conjugates","volume":"20","author":"Manohar","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.11.021_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1747-0285.2011.01115.x","article-title":"Synthesis of 4-aminoquinoline-1,2,3-triazole and 4-aminoquinoline-1,2,3-triazole-1,3,5-triazine hybrids as potential antimalarial agents","volume":"78","author":"Manohar","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2018.11.021_bib16","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.ejmech.2011.04.002","article-title":"Synthesis and in\u00a0vitro antimalarial activity of tetraoxane-amine\/amide conjugates","volume":"46","author":"Kumar","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.021_bib17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1021\/ml3000808","article-title":"Novel 4-aminoquinoline-pyrimidine based hybrids with improved in\u00a0vitro and in\u00a0vivo antimalarial activity","volume":"3","author":"Manohar","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.11.021_bib18","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1039\/c3md00329a","article-title":"Synthesis and anticancer activity evaluation of resveratrol-chalcone conjugates","volume":"5","author":"Kumar","year":"2014","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2018.11.021_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejmech.2014.05.005","article-title":"Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in\u00a0vitro and in\u00a0vivo antimycobacterial activity evaluation","volume":"81","author":"Kumar","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.021_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jfluchem.2012.03.003","article-title":"Br\u00f8nsted acidic ionic liquids: green, efficient and reusable catalyst for synthesis of fluorinated spiro [indole-thiazinones\/thiazolidinones] as antihistamic agents","volume":"137","author":"Arya","year":"2012","journal-title":"J.\u00a0Fluorine Chem."},{"key":"10.1016\/j.ejmech.2018.11.021_bib21","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1039\/C4NJ00978A","article-title":"Triazine\u2013pyrimidine based molecular hybrids: synthesis, docking studies and evaluation of antimalarial activity","volume":"38","author":"Kumar","year":"2014","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2018.11.021_bib22","doi-asserted-by":"crossref","first-page":"18142","DOI":"10.1039\/c3ra42410c","article-title":"Ethylenediammonium-diformate (EDDF) in PEG600: an efficient ambiphilic novel catalytic system for the one-pot synthesis of 4H-pyrans via Knoevenagel condensation","volume":"3","author":"Thakur","year":"2013","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2018.11.021_bib23","first-page":"275","article-title":"A\u00a0stacked pyarazolo[3,4,-d]pyrimidine based flexible molecules","volume":"C54","author":"Maulik","year":"1998","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.ejmech.2018.11.021_bib24","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1021\/jm0108707","article-title":"Novel short chain chloroquine analogues retain activity against chloroquine-resistant K1 Plasmodium falciparum","volume":"45","author":"Stocks","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.021_bib25","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.bmc.2015.02.061","article-title":"Investigation into novel thiophene- and furan-based 4-amino-7-chloroquinolines afforded antimalarials that cure mice","volume":"23","author":"Opsenica","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.021_bib26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1021\/jm00274a010","article-title":"Naphthothiophenes. 1-(Alkylaminomethyl)-4-naphtho[2,b] thiophenemethanols as antimalarials","volume":"15","author":"Das","year":"1972","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.021_bib27","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.1016\/j.bmc.2005.06.052","article-title":"Synthesis of 4-pyrido-6-aryl-2-substituted amino pyrimidines as a new class of antimalarial agents","volume":"13","author":"Agarwal","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.021_bib28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1021\/ml300419r","article-title":"Antimalarial and structural studies of Pyridine-containing inhibitors of 1-deoxyxylulose-5-phosphate reductoisomerase","volume":"4","author":"Xue","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.11.021_bib29","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.bmc.2004.12.051","article-title":"Design and synthesis of new antimalarial agents from 4-aminoquinoline","volume":"13","author":"Solomon","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.021_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0162-0134(97)00086-X","article-title":"Thermodynamic factors controlling the interaction of quinoline antimalarial drugs with ferriprotoporphyrin IX","volume":"68","author":"Egan","year":"1997","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2018.11.021_bib31","series-title":"QikProp, Version 3.5","year":"2012"},{"key":"10.1016\/j.ejmech.2018.11.021_bib32","unstructured":"QikProp User Manual Copyright \u00a9 2013 Schr\u00f6dinger, LLC."},{"key":"10.1016\/j.ejmech.2018.11.021_bib33","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.chembiol.2014.08.013","article-title":"Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates","volume":"21","author":"Doak","year":"2014","journal-title":"Chem. Biol. (Lond.)"},{"key":"10.1016\/j.ejmech.2018.11.021_bib34","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1021\/jm0306529","volume":"47","author":"Lu","year":"2004","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418309796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418309796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:52:10Z","timestamp":1759326730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418309796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":34,"alternative-id":["S0223523418309796"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.11.021","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-Substituted aminoquinoline-pyrimidine hybrids: Synthesis, in\u00a0vitro antimalarial activity evaluation and docking studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}